Guangzhou Improve Med Instrument (300030) — Working Capital to Net Assets Ratio
Guangzhou Improve Med Instrument (300030) has a Working Capital to Net Assets ratio of 19.9% as of March 2026. Working capital of CN¥134.60 Million (current assets of CN¥430.17 Million minus current liabilities of CN¥295.56 Million) is measured against net assets of CN¥677.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Guangzhou Improve Med Instrument net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangzhou Improve Med Instrument Working Capital to Net Assets (2006–2025)
This chart shows how Guangzhou Improve Med Instrument's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 19.9%, reflecting working capital of CN¥134.60 Million against net assets of CN¥677.10 Million CNY. Check 300030 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Guangzhou Improve Med Instrument (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangzhou Improve Med Instrument from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 300030 market cap overview.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.1% | CN¥105.47 Million | CN¥655.10 Million | CN¥423.34 Million | CN¥317.87 Million | ▲ +4.1 pp |
| 2024 | 12.0% | CN¥77.03 Million | CN¥643.86 Million | CN¥589.10 Million | CN¥512.07 Million | ▲ +4.0 pp |
| 2023 | 8.0% | CN¥61.06 Million | CN¥762.33 Million | CN¥664.43 Million | CN¥603.37 Million | ▼ -1.7 pp |
| 2022 | 9.7% | CN¥79.78 Million | CN¥820.61 Million | CN¥718.24 Million | CN¥638.46 Million | ▼ -6.4 pp |
| 2021 | 16.1% | CN¥166.30 Million | CN¥1.03 Billion | CN¥843.94 Million | CN¥677.64 Million | ▼ -23.3 pp |
| 2020 | 39.4% | CN¥395.41 Million | CN¥1.00 Billion | CN¥860.05 Million | CN¥464.63 Million | ▲ +24.1 pp |
| 2019 | 15.3% | CN¥128.21 Million | CN¥838.26 Million | CN¥702.19 Million | CN¥573.98 Million | ▼ -34.2 pp |
| 2018 | 49.5% | CN¥403.65 Million | CN¥815.47 Million | CN¥715.88 Million | CN¥312.22 Million | ▲ +2.1 pp |
| 2017 | 47.4% | CN¥456.54 Million | CN¥963.72 Million | CN¥749.37 Million | CN¥292.83 Million | ▲ +28.2 pp |
| 2016 | 19.2% | CN¥183.33 Million | CN¥954.18 Million | CN¥596.05 Million | CN¥412.73 Million | ▼ -5.6 pp |
| 2015 | 24.8% | CN¥230.66 Million | CN¥930.46 Million | CN¥603.78 Million | CN¥373.12 Million | ▼ -8.4 pp |
| 2014 | 33.2% | CN¥259.44 Million | CN¥782.00 Million | CN¥450.38 Million | CN¥190.94 Million | ▼ -25.8 pp |
| 2013 | 59.0% | CN¥455.72 Million | CN¥772.70 Million | CN¥537.79 Million | CN¥82.07 Million | ▲ +0.7 pp |
| 2012 | 58.3% | CN¥400.80 Million | CN¥687.93 Million | CN¥467.15 Million | CN¥66.35 Million | ▼ -4.8 pp |
| 2011 | 63.1% | CN¥408.88 Million | CN¥648.25 Million | CN¥468.90 Million | CN¥60.02 Million | ▼ -11.6 pp |
| 2010 | 74.7% | CN¥442.46 Million | CN¥592.55 Million | CN¥495.37 Million | CN¥52.91 Million | ▼ -9.6 pp |
| 2009 | 84.2% | CN¥474.75 Million | CN¥563.53 Million | CN¥547.20 Million | CN¥72.45 Million | ▲ +38.4 pp |
| 2008 | 45.8% | CN¥36.06 Million | CN¥78.73 Million | CN¥79.98 Million | CN¥43.92 Million | ▼ -21.8 pp |
| 2007 | 67.6% | CN¥39.38 Million | CN¥58.27 Million | CN¥53.95 Million | CN¥14.56 Million | ▲ +21.8 pp |
| 2006 | 45.8% | CN¥8.84 Million | CN¥19.33 Million | CN¥28.07 Million | CN¥19.22 Million | — |